• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过非遗传异质性理解乳腺癌异质性。

Understanding breast cancer heterogeneity through non-genetic heterogeneity.

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Breast Cancer. 2021 Jul;28(4):777-791. doi: 10.1007/s12282-021-01237-w. Epub 2021 Mar 15.

DOI:10.1007/s12282-021-01237-w
PMID:33723745
Abstract

Intricacy in treatment and diagnosis of breast cancer has been an obstacle due to genotype and phenotype heterogeneity. Understanding of non-genetic heterogeneity mechanisms along with considering role of genetic heterogeneity may fill the gaps in landscape painting of heterogeneity. The main factors contribute to non-genetic heterogeneity including: transcriptional pulsing/bursting or discontinuous transcriptions, stochastic partitioning of components at cell division and various signal transduction from tumor ecosystem. Throughout this review, we desired to provide a conceptual framework focused on non-genetic heterogeneity, which has been intended to offer insight into prediction, diagnosis and treatment of breast cancer.

摘要

由于基因型和表型异质性,乳腺癌的治疗和诊断的复杂性一直是一个障碍。了解非遗传异质性机制以及考虑遗传异质性的作用可能会填补异质性景观图中的空白。导致非遗传异质性的主要因素包括:转录脉冲/爆发或不连续转录、细胞分裂时组件的随机分配以及来自肿瘤生态系统的各种信号转导。在本综述中,我们旨在提供一个关注非遗传异质性的概念框架,旨在为乳腺癌的预测、诊断和治疗提供深入了解。

相似文献

1
Understanding breast cancer heterogeneity through non-genetic heterogeneity.通过非遗传异质性理解乳腺癌异质性。
Breast Cancer. 2021 Jul;28(4):777-791. doi: 10.1007/s12282-021-01237-w. Epub 2021 Mar 15.
2
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy.乳腺肿瘤异质性:适应度之源,治疗之碍。
Mol Cell. 2015 Nov 19;60(4):537-46. doi: 10.1016/j.molcel.2015.10.031.
3
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.缺氧诱导因子对乳腺癌干细胞表型的调控
Clin Sci (Lond). 2015 Dec;129(12):1037-45. doi: 10.1042/CS20150451.
4
[Tumor stem cells in breast cancer].[乳腺癌中的肿瘤干细胞]
Arkh Patol. 2015 Sep-Oct;77(5):64-67. doi: 10.17116/patol201577564-67.
5
Heterogeneity of breast cancer: etiology and clinical relevance.乳腺癌的异质性:病因学和临床相关性。
Clin Transl Oncol. 2011 Nov;13(11):767-73. doi: 10.1007/s12094-011-0731-9.
6
Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.微环境网络促进肿瘤异质性,并在腔面A型乳腺肿瘤细胞中富集转移性癌干细胞样细胞。
Oncotarget. 2016 Dec 6;7(49):81123-81143. doi: 10.18632/oncotarget.13213.
7
Breast cancer intra-tumor heterogeneity.乳腺癌瘤内异质性
Breast Cancer Res. 2014 May 20;16(3):210. doi: 10.1186/bcr3658.
8
Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.靶向乳腺癌干细胞中的细胞信号通路及其对癌症治疗的意义。
Anticancer Res. 2016 Nov;36(11):5681-5691. doi: 10.21873/anticanres.11151.
9
JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.JNK1应激信号在乳腺密度高和肿瘤基质中过度激活:将纤维化、炎症和干性联系起来以预防癌症。
Cell Cycle. 2014;13(4):580-99. doi: 10.4161/cc.27379. Epub 2013 Dec 5.
10
The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors.肿瘤干细胞表型作为乳腺癌异质性决定因素。
Crit Rev Oncol Hematol. 2017 May;113:111-121. doi: 10.1016/j.critrevonc.2017.03.016. Epub 2017 Mar 16.

引用本文的文献

1
Prognostic implications of complement C1q-like 4 expression in breast cancer.补体C1q样蛋白4在乳腺癌中的表达对预后的影响
Sci Rep. 2025 Jul 24;15(1):26868. doi: 10.1038/s41598-025-12557-8.
2
Prediction models of breast cancer molecular subtypes based on multimodal ultrasound and clinical features.基于多模态超声和临床特征的乳腺癌分子亚型预测模型
BMC Cancer. 2025 May 19;25(1):886. doi: 10.1186/s12885-025-14233-6.
3
Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics.

本文引用的文献

1
The critical role of T cells in glucocorticoid-induced osteoporosis.T 细胞在糖皮质激素诱导性骨质疏松中的关键作用。
Cell Death Dis. 2020 Dec 14;12(1):45. doi: 10.1038/s41419-020-03249-4.
2
An update to the Monro-Kellie doctrine to reflect tissue compliance after severe ischemic and hemorrhagic stroke.对 Monro-Kellie 学说的更新,以反映严重缺血性和出血性卒中后的组织顺应性。
Sci Rep. 2020 Dec 16;10(1):22013. doi: 10.1038/s41598-020-78880-4.
3
Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model.
乳腺癌中的非遗传异质性与免疫亚型:对免疫治疗和靶向治疗的启示
Transl Oncol. 2024 Sep;47:102055. doi: 10.1016/j.tranon.2024.102055. Epub 2024 Jul 13.
4
CRIPTO-based micro-heterogeneity of mouse muscle satellite cells enables adaptive response to regenerative microenvironment.基于CRIPTO 的小鼠肌肉卫星细胞的微观异质性使它们能够对再生微环境产生适应性反应。
Dev Cell. 2023 Dec 18;58(24):2896-2913.e6. doi: 10.1016/j.devcel.2023.11.009. Epub 2023 Dec 5.
5
Analysis of Changes in the Expression of Selected Genes from the Family in Patients with Triple-Negative Breast Cancer.分析家族中选定基因在三阴性乳腺癌患者中的表达变化。
Int J Mol Sci. 2023 Jan 9;24(2):1257. doi: 10.3390/ijms24021257.
6
Evaluation of Adjuvant Treatments for Adenoid Cystic Carcinoma of the Breast: A Population-Based, Propensity Score Matched Cohort Study from the SEER Database.乳腺腺样囊性癌辅助治疗的评估:一项基于监测、流行病学和最终结果(SEER)数据库的人群倾向评分匹配队列研究。
Diagnostics (Basel). 2022 Jul 21;12(7):1760. doi: 10.3390/diagnostics12071760.
β-羟基丁酸是一种内源性NLRP3炎性小体抑制剂,可减轻啮齿动物创伤后应激障碍模型中的焦虑相关行为。
Sci Rep. 2020 Dec 10;10(1):21629. doi: 10.1038/s41598-020-78410-2.
4
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.RON 信号促进 ESR1 突变型乳腺癌的治疗抵抗。
Br J Cancer. 2021 Jan;124(1):191-206. doi: 10.1038/s41416-020-01174-z. Epub 2020 Dec 1.
5
The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence.黑色素瘤脑转移作为首发内脏转移部位的突变特征。
Br J Cancer. 2021 Jan;124(1):156-160. doi: 10.1038/s41416-020-01090-2. Epub 2020 Oct 7.
6
Systems biology approaches to measure and model phenotypic heterogeneity in cancer.用于测量和建模癌症表型异质性的系统生物学方法。
Curr Opin Syst Biol. 2019 Oct;17:35-40. doi: 10.1016/j.coisb.2019.09.002. Epub 2019 Sep 11.
7
Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment.旁观者 IFN-γ 活性促进广泛而持续的细胞因子信号转导,改变肿瘤微环境。
Nat Cancer. 2020 Mar;1(3):302-314. doi: 10.1038/s43018-020-0038-2. Epub 2020 Mar 9.
8
Control strategies in systemic metabolism.全身代谢的控制策略。
Nat Metab. 2019 Oct;1(10):947-957. doi: 10.1038/s42255-019-0118-8. Epub 2019 Oct 7.
9
Multiplex Spatial Bioimaging for Combination Therapy Design.多重空间生物成像用于联合治疗设计。
Trends Cancer. 2020 Oct;6(10):813-818. doi: 10.1016/j.trecan.2020.05.003. Epub 2020 May 25.
10
Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression.基质反应差异驱动肿瘤细胞进化和前列腺癌进展。
Nat Ecol Evol. 2020 Jun;4(6):870-884. doi: 10.1038/s41559-020-1157-y. Epub 2020 May 11.